University of London

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

University of London
Jun 4, 2025, 04:07 | Blog
Tom Powles: Unsung Prostate Cancer Hero - David Olmos
Tom Powles, Professor at the University of London and Director of Barts Cancer Centre, shared a…
May 1, 2025, 10:44 | Blog
Petros Grivas: 'Embarrassment of riches' in BCG-unresponsive NMIBC
Tom Powles, Professor at the University of London and Director of Barts Cancer Centre, shared…
Apr 29, 2025, 10:50 | Blog
Tom Powles: Podcast with Neal Shore around the CREST RIII untreated NMIBC BCG +/- PD1 trial
Tom Powles, Professor at the University of London, shared a post on X: "Here is a…
Feb 16, 2025, 19:10 | Insight
Highlights by Tom Powles from ASCO GU25
At ASCO GU 2025, Professor Tom Powles, Professor at the University of London, highlighted key…
Feb 16, 2025, 04:58 | Blog
Tom Powles: TROPICS4 - sacituzimab govitecan vs chemo in pretreated urothelial carcinoma
Tom Powles, Professor at the University of London, shared a post on X: "TROPICS4 sacituzimab…
Feb 8, 2025, 07:02 | Blog
Tom Powles: Bladder cancer highlights at ASCOGU25
Tom Powles, Professor at the University of London and Director of Barts Cancer Centre, shared…
Jan 29, 2025, 18:32 | Career
Karen H. Vousden - Candidate for the Nominating Committee of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Dec 30, 2024, 06:41 | Insight
Tom Powles: TIGIT and LAG3 targets have been explored
Tom Powles, Professor at the University of London, posted the following on X: “TIGIT and…
Dec 9, 2024, 14:39 | Blog
Tom Powles: Terry Friedlander highlights multiple factors why SG did not beat chemotherapy in UC
 Tom Powles, Professor at the University of London, shared a post on X: "TROPICS4 discusses…
Nov 5, 2024, 17:40 | Blog
Tom Powles: First-Line UC Trials - Ipi/Nivo Fails on OS, Durva/Treme Shows Potential in PD-L1 Positive Patients
Tom Powles, Director of Barts Cancer Centre, shared a post on X: "Just out. Ipi/nivo…
Sep 20, 2024, 12:57 | Blog
Neeraj Agarwal: The 1st results of the ph3 Niagara trial of cisplatin + gemcitabine +/- durvalumab in MIBC
Neeraj Agarwal shared a post on X: "Breaking news (practice changing) from ESMO24, Tom Powles…
Sep 20, 2024, 12:55 | Insight
Tom Powles: The 1st disitimab Vedotin and pembro in HER 1-3 urothelial carcinomas
Tom Powles shared a post on X: "The 1st disitimab Vedotin (HER-2 MMAE ADC) and…
Sep 17, 2024, 16:42 | Blog
Tom Powles: SUNNIFORCAST at ESMO24
Tom Powles shared a post on X: "SUNNIFORCAST at ESMO24 ipi/nivo vs VEGF based therapy…
Aug 14, 2024, 12:07 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Tom Powles
We are excited to spotlight Dr. Tom Powles, a leading expert in urological oncology, as…
Jul 20, 2024, 18:07 | Blog
Tom Powles: More evidence that PD(L)1 re-challenge should be avoided in renal cancer
Tom Powles posted on X/Twitter: "More evidence that PD(L)1 re-challenge should be avoided in renal…
All: 15 Posts: 1 - 100
Special Coverage